drugset / Trial / NCT04977674

Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine

NCT04977674

Phase 0 Completed 27 enrolled King's College London
RandomizedCrossoverQuadruple-blindBasic science

Summary

The overarching aim of this research is to determine the acute effects of ketamine on brain glutamate, functional connectivity and cerebral blood flow in treatment-resistant depression, explore whether the effects are attenuated by the opioid receptor antagonist naltrexone and relate these findings to antidepressant response.

Timeline

Start
2021-09-27
Primary completion
2023-02-13
Completion
2023-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous
Subject Naltrexone Small molecule 50 mg Oral